Rowinsky Eric K has filed 16 insider transactions across 3 companies since September 2017.
Most recent transaction: a grant/award of 2370 shares of BIOGEN INC. ($BIIB) on June 17, 2025.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 17, 2025 | BIOGEN INC. | $BIIB | Rowinsky Eric K | Director | A | Common Stock | 2370 | $0.00 | 24,339.0000 | 169,500,000 | 10.79% | 0.00% |
| May 22, 2025 | Verastem, Inc. | $VSTM | Rowinsky Eric K | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 54,173,000 | 9999.99% | 0.02% |
| May 22, 2025 | Verastem, Inc. | $VSTM | Rowinsky Eric K | Director | A | Common Stock | 8333 | $0.00 | 16,666.0000 | 54,173,000 | 100.00% | 0.02% |
| June 21, 2024 | BIOGEN INC. | $BIIB | Rowinsky Eric K | Director | A | Common Stock | 1340 | $0.00 | 21,969.0000 | 168,700,000 | 6.50% | 0.00% |
| June 18, 2024 | Verastem, Inc. | $VSTM | Rowinsky Eric K | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 26,832,000 | 9999.99% | 0.05% |
| June 18, 2024 | Verastem, Inc. | $VSTM | Rowinsky Eric K | Director | A | Common Stock | 8333 | $0.00 | 8,333.0000 | 26,832,000 | 9999.99% | 0.03% |
| March 11, 2024 | Verastem, Inc. | $VSTM | Rowinsky Eric K | Director | D | Stock Option (right to buy) | 4166 | $0.00 | 0.0000 | 22,054,000 | 100.00% | 0.02% |
| March 11, 2024 | Verastem, Inc. | $VSTM | Rowinsky Eric K | Director | D | Stock Option (right to buy) | 2083 | $0.00 | 0.0000 | 22,054,000 | 100.00% | 0.01% |
| March 11, 2024 | Verastem, Inc. | $VSTM | Rowinsky Eric K | Director | D | Stock Option (right to buy) | 2083 | $0.00 | 0.0000 | 22,054,000 | 100.00% | 0.01% |
| March 11, 2024 | Verastem, Inc. | $VSTM | Rowinsky Eric K | Director | D | Stock Option (right to buy) | 2083 | $0.00 | 0.0000 | 22,054,000 | 100.00% | 0.01% |
| March 11, 2024 | Verastem, Inc. | $VSTM | Rowinsky Eric K | Director | A | Stock Option (right to buy) | 12572 | $0.00 | 12,572.0000 | 22,054,000 | 9999.99% | 0.06% |
| March 11, 2024 | Verastem, Inc. | $VSTM | Rowinsky Eric K | Director | D | Stock Option (right to buy) | 2157 | $0.00 | 0.0000 | 22,054,000 | 100.00% | 0.01% |
| Feb. 15, 2024 | BIOGEN INC. | $BIIB | Rowinsky Eric K | Director | P | Common Stock | 455 | $222.54 | 20,629.0000 | 168,700,000 | 2.26% | 0.00% |
| Sept. 5, 2017 | Verastem, Inc. | $VSTM | Rowinsky Eric K | Director | P | Common Stock | 2000 | $3.84 | 2,000.0000 | 36,988,000 | 9999.99% | 0.01% |
| Jan. 1, 2024 | Fortress Biotech, Inc. | $FBIO | Rowinsky Eric K | Director | A | COMMON STOCK, PAR VALUE $0.001 | 6666 | $0.00 | 68,797.0000 | 8,110,906 | 10.73% | 0.08% |
| June 26, 2023 | BIOGEN INC. | $BIIB | Rowinsky Eric K | Director | A | Common Stock | 960 | $0.00 | 20,174.0000 | 167,900,000 | 5.00% | 0.00% |